Your browser doesn't support javascript.
loading
RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers.
Jones, Wendell D; Michener, Chad M; Biscotti, Charles; Braicu, Iona; Sehouli, Jalid; Ganapathi, Mahrukh K; Ganapathi, Ram N.
Afiliação
  • Jones WD; Bioinformatics Group, Q2 Solutions - EA Genomics, 5927 S Miami Blvd, Morrisville, NC 27560, USA.
  • Michener CM; Division of Gynecologic Oncology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
  • Biscotti C; Department of Anatomic Pathology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
  • Braicu I; Department of Gynecology, Charité Medical University of Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
  • Sehouli J; Department of Gynecology, Charité Medical University of Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
  • Ganapathi MK; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas Medical Center, 1021 Morehead Medical Drive, Charlotte, NC 28204, USA.
  • Ganapathi RN; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas Medical Center, 1021 Morehead Medical Drive, Charlotte, NC 28204, USA.
Cancers (Basel) ; 12(3)2020 Mar 07.
Article em En | MEDLINE | ID: mdl-32156016

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article